Unlocking the post-transplant microenvironment for successful islet function and survival.

Area of Science:

• Endocrinology
• Regenerative Medicine
• Biomaterials Science

Background:

• Islet transplantation (IT) aims to restore normal blood glucose (euglycemia) in type 1 diabetes mellitus (T1DM) patients.
• Current IT outcomes are suboptimal, with low five-year graft survival rates and persistent insulin dependence.
• Native islets possess a crucial extracellular matrix (ECM) microenvironment that is disrupted during isolation.

Purpose of the Study:

• To investigate the role of the implantation site microenvironment and its interaction with transplanted islets.
• To explore how extracellular matrix (ECM) deposition influences islet survival and function.
• To identify potential therapeutic interventions for improving islet transplantation and stem-cell derived beta-cell therapy.

Main Methods:

• Analysis of islet isolation techniques and their impact on the native ECM.
• Examination of the host response at various implantation sites, including the liver, kidney capsule, and eye chamber.
• Investigation of fibroblast and ECM interactions with transplanted islets.

Main Results:

• Collagenase isolation disrupts the native islet ECM, increasing transplanted islet vulnerability.
• A host fibroblast response and ECM deposition at implantation sites can be beneficial for islet survival.
• The liver's response to portal venous transplantation may involve inflammation and ECM deposition impacting islet function.

Conclusions:

• Understanding the interplay between transplanted islets and the implantation site microenvironment is critical.
• Modulating the ECM at implantation sites presents a promising strategy to enhance islet graft survival and function.
• This research could lead to improved outcomes for islet transplantation and future beta-cell therapies.